JENNIFER DOWLING: Open Payments
NPI 1770098410 · ALMA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 58 payments from 17 companies in 2025. Trend: 2023 $1,146 · 2024 $1,313 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $266 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| ABBVIE INC. | 9 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $98 |
| SANOFI-AVENTIS U.S. LLC | 5 | $87 |
| Antares Pharma, Inc. | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $58 |
| Lilly USA, LLC | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: Wegovy, VRAYLAR, Kerendia, TZIELD, FARXIGA, XYOSTED, GEMTESA, SYMBICORT.
Industry payments across GA — which companies pay providers there.
